financetom
Business
financetom
/
Business
/
Bandhan Bank Q2 profit down 5% at Rs 920 cr
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Bandhan Bank Q2 profit down 5% at Rs 920 cr
Nov 2, 2020 6:16 AM

Bandhan Bank on Monday reported 5.3 percent decline in net profit at Rs 920 crore for September quarter of the current fiscal year. The bank clocked a net profit of Rs 971.80 crore in the same period of 2019-20.

Total income grew 22 percent to Rs 2,304.90 crore in July-September 2020-21 as against Rs 1,889.30 crore in the year-ago period, Bandhan Bank said in a regulatory filing. Net interest income of the Kolkata-headquartered lender jumped 25.8 percent to Rs 1,923.1 crore during the quarter while the non-interest income grew 6.1 percent to Rs 381.8 crore.

Bandhan Bank said it has reported the highest ever quarterly profit before tax at Rs 1,233 crore during the period under review. Net Interest Margin (annualised) in the quarter fell to 8 percent against 8.2 percent in year-ago period. During the quarter, the bank took accelerated additional provision on standard advances amounting to Rs 300 crore. With this provision and the additional standard assets provision that bank is carrying in micro banking portfolio, the total additional provision in books stands at Rs 2,096 crore, it said.

The bank’s gross non-performing assets fell to 1.2 percent (Rs 874 crore) of gross advances as of September 30, 2020 as against 1.8 percent (Rs 1,064.20 crore) by the year-ago same period. Net NPAs too improved to 0.4 percent (Rs 262.50 crore) from 0.6 percent (Rs 336.90 crore).

”As the moratorium ended on 31st August 2020 coupled with robust rural performance, we have seen an all-round improvement in collection, disbursement and deposits. On deposits front, we have witnessed the best ever quarter whereas on the disbursement front, we are close to pre-COVID-19 level.”

Collections have seen a steady improvement month-on-month and is expected to reach near normal in the next 90 days. We now look forward to accelerate the business in H2FY 21,” Managing Director and CEO Chandra Shekhar Ghosh said. Total Advances grew 19.4 percent to Rs 76,614.6 crore as on September 30, 2020. Total deposits increased 34.4 percent to Rs 66,127.7 crore.

Bandhan Bank stock was trading at Rs 305.50 on BSE, up 5.62 percent from the previous close.

First Published:Nov 2, 2020 3:16 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Dialysis firms gain as Ozempic kidney trial data disappoints
Dialysis firms gain as Ozempic kidney trial data disappoints
Mar 5, 2024
(Reuters) - Shares of dialysis services providers jumped in early trading on Tuesday after Novo Nordisk's popular diabetes drug Ozempic fell short of some expectations when tested on patients with chronic kidney disease. Colorado-based DaVita ( DVA ) rose 7.4%, while the U.S.-listed shares of rival Fresenius Medical were up 9.5% in early trading. Baxter International ( BAX ), which...
Blackcat ransomware site claims it was seized; UK law enforcement denies being behind disruption
Blackcat ransomware site claims it was seized; UK law enforcement denies being behind disruption
Mar 5, 2024
WASHINGTON, March 5 (Reuters) - The website used by the hackers responsible for the breach at UnitedHealth Group ( UNH ) has been replaced by a notice claiming it was seized by international law enforcement. But at least one of the law enforcement agencies allegedly responsible for taking the gang down says it had nothing to do with the operation,...
DexCom Says Use of Automated Insulin Delivery System Reduces Hypoglycemia in Diabetes Patients
DexCom Says Use of Automated Insulin Delivery System Reduces Hypoglycemia in Diabetes Patients
Mar 5, 2024
09:54 AM EST, 03/05/2024 (MT Newswires) -- DexCom ( DXCM ) said Tuesday it has real world evidence showing that the use of its automated insulin delivery system powered by its continuous glucose monitoring, or CGM, technology can reduce severe hypoglycemia and ketoacidosis in patients with type 1 diabetes over 12 months. The company also said it has evidence showing...
Meta Platforms Signs Solar Energy Deals With Arevon Energy
Meta Platforms Signs Solar Energy Deals With Arevon Energy
Mar 5, 2024
09:52 AM EST, 03/05/2024 (MT Newswires) -- Meta Platforms ( META ) and renewable energy developer Arevon Energy said Tuesday that they signed two long-term environmental attributes purchase agreements over the Kelso solar project in Missouri. Arevon will own and operate the Kelso solar project and the facility is expected to provide renewable energy that will support Meta's operations in...
Copyright 2023-2026 - www.financetom.com All Rights Reserved